Señales en vivo de ABSI | Maximiza tus Ganancias con Getagraph.com

COMPRAR 136909 min ago

@ $4.70

Emitido: 14 feb 2024 @ 14:13

Retorno: -1.81%

Señal anterior: feb 13 - 11:04

Señal anterior: Vender

Retorno: 12.71 %

Live Chart Being Loaded With Signals

Commentary (17 may 2024 @ 16:00):

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States...

Stats
Volumen de hoy	545 040
Volumen promedio	1.33M
Capitalización de mercado	521.88M
EPS	$0 ( 2024-05-14 )
Próxima fecha de ganancias	( $-0.190 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.85
ATR14	$0.00700 (0.15%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-19	Mcclain Sean	Buy	1 500 000	Common Stock
2024-03-01	Redmile Group, Llc	Buy	222 222	Common Stock
2023-12-31	Phoenix Venture Partners Ii Lp	Buy	0
2024-02-01	Bedrick Todd	Buy	20 570	Common Stock
2024-02-01	Bedrick Todd	Buy	86 790	Stock Option (right to buy)

INSIDER POWER
99.64
Last 93 transactions
Buy: 45 572 968 \| Sell: 7 130 968

Volumen Correlación

Largo: 0.22 (neutral)

Corto: 0.98 (very strong)

Signal:(61.882) Expect same movement, but be aware

Absci Corporation Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Absci Corporation Correlación - Moneda/Commodity

0.42
( neutral )

0.33
( neutral )

0.00
( neutral )

-0.31
( neutral )

-0.35
( neutral )

Absci Corporation Finanzas

Annual	2023
Ingresos:	$5.72M
Beneficio Bruto:	$-8.28M (-144.82 %)
EPS:	$-1.200

FY	2023
Ingresos:	$5.72M
Beneficio Bruto:	$-8.28M (-144.82 %)
EPS:	$-1.200

FY	2022
Ingresos:	$5.75M
Beneficio Bruto:	$-7.29M (-126.85 %)
EPS:	$-1.150

FY	2021
Ingresos:	$4.78M
Beneficio Bruto:	$-1.87M (-39.15 %)
EPS:	$-1.117

Financial Reports:

No articles found.

Absci Corporation Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Absci Corporation

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Actualizaciones en tiempo real para Absci Corporation [ABSI]

Upcoming Earnings Alert

Absci Corporation Options Data

Calls

Puts